Business Standard
Rain Industries reported a net loss of Rs 1,118.75 crore in Q4 FY23 as against net profit of Rs 89.52 crore in Q4 FY22.
Sebi Whole Time Member Kamlesh Chandra Varshney on Saturday cautioned against manipulations in the capital market and urged brokers to keep an eye and
Aditya Birla Capital announced that it has made an investment of Rs 50 crore in its wholly owned subsidiary, Aditya Birla Capital Digital (ADBCDL) on
Advait Infratech (AIL) said that it has entered into IT/IoT domain to undertake the development of software and the integration of solar pump devices/
Zen Technologies announced that it will acquire 51% stake in AiTuring Technologies for total consideration of approximately Rs 3.87 crore.
With the above , Advait Infratech, marking its entry into the IT/loT domain, will undertake the development of software and the integration of solar p
RITES said that Infomerics Valuation and Rating (IVR) has reaffirmed long-term rating on the credit facitilies of the company at 'IVR AAA' with a 'sta
Zaggle Prepaid Ocean Services said that it has entered into an agreement with Benetton India for providing the latter with Zaggle Save proposition, an
AiTuring Technologies offers a comprehensive suite of solutions for electronic optics and robotics and is committed to focused research and developmen
Sanofi India reported 5.19% jump in net profit to Rs 137.7 crore in Q4 FY24 as compared with Rs 130.9 crore in Q3 FY23.
The price of 22-carat gold also fell Rs 10 with the yellow metal selling at Rs 57,490
The initial share sale of GPT Healthcare Ltd, which operates and manages mid-sized multi-specialty hospitals under the ILS Hospitals brand, received 8
Plans to give index funds, ETFs exemption from 25% investment cap in group firms
The company's Rs 1,800-crore IPO was entirely a fresh issue and was priced between Rs 342 to Rs 360 per share. At the top end of the price band, Junip
The offer received bids for 5.99 crore shares as against 2.89 crore shares on offer.
Domestic stock market closed flat on Friday after reaching record highs in early trade. Investor caution prevailed due to upcoming releases of key dom
The offer received bids for 1.67 crore shares as against 197.63 crore shares on offer.
Orchid Pharma has received approval by the United States Food and Drug Administration (USFDA) for its novel invention, Enmetazobactam'. This developme
The Indian rupee consolidated in a narrow range and depreciated by 8 paise to close at 82.93 (provisional) against the US dollar on Friday, tracking a
The offer received bids for 57.78 lakh shares as against 40.18 lakh shares on offer.
